DRAP seeks opinion on generic medicines registration
National
May 12, 2021
Islamabad: Drug Regulatory Authority of Pakistan (DRAP) Tuesday decided to take initiative on the issue of registration of a generic basis for all single-ingredient drugs in consultation with relevant stakeholders.
In this regard DRAP’s Division of Pharmaceutical Evaluation and Registration has sought an opinion from stakeholders on generic medicines, an official of DRAP said. He said that DRAP’s initiative on this matter is in compliance with the law for generic medicines like the Drugs Act 1976 and rules framed there under which is part of the DRAP Act 2012 under Schedule -VI.
PMA rejects DRAP notification on generic prescriptions
National
April 22, 2021
LAHORE: The Pakistan Medical Association (PMA) is concerned over a notification issued by the Drug Regulatory Authority of Pakistan, directing Health Departments to ensure that doctors prescribe generic names rather than brand names of medicines.
In a statement on Wednesday, PMA (Centre) Secretary General Dr S.M.Qaisar Sajjad said the PMA condemns this move because issuing such directives is beyond the domain of the DRAP. It has exceeded its authority which is unlawful. The government should have contacted stakeholders and discussed the issue at large before making such a policy.